Differentiated Small Molecules for Solid Tumors and Hematopoietic Malignancies
Project introduction: Established in 2010, the target company focuses on small molecule medicines which are used for cancer and immune system disorders. It has built a rich pipeline based on proprietary discovery platforms, TALENTTM, FD2TM and PD2TM. The company is looking for partners to develop…
BioToChina.org 